MEDI Among Health Care ETFs
End-of-day Nov 19, 2026 · 31 Health care ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.3% | −4.5% | +2.8% | −1.5% | +9.6% | +8.9% | +58.3% | — | — | +79.5% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$211 of every $1,000 in MEDI is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 21.15% | $2,114.61 | 6,275 | $8.7M |
| 2 | —Ascendis Pharma A/S | — | 17.49% | $1,748.84 | 27K | $7.2M |
| 3 | ARGNFArgenx SE | — | 5.03% | $502.60 | 2,191 | $2.1M |
| 4 | GHGuardant Health | Healthcare | 3.45% | $344.81 | 9,748 | $1.4M |
| 5 | UTHRUnited Therapeutics | Healthcare | 3.26% | $326.01 | 2,317 | $1.3M |
| 6 | INSMInsmed | Healthcare | 3.25% | $325.13 | 11K | $1.3M |
| 7 | PCVXVaxcyte | Healthcare | 3.23% | $322.63 | 23K | $1.3M |
| 8 | RYTMRhythm Pharmaceuticals | Healthcare | 3.18% | $318.17 | 11K | $1.3M |
| 9 | IDXXIdexx Laboratories | Healthcare | 2.60% | $259.93 | 1,527 | $1.1M |
| 10 | RVMDRevolution Medicines | Healthcare | 2.52% | $251.73 | 6,463 | $1.0M |
| 11 | CORCencora | Healthcare | 2.23% | $222.74 | 2,624 | $914K |
| 12 | NTRANatera | Healthcare | 1.98% | $197.90 | 2,805 | $812K |
| 13 | UNHUnitedhealth Group | Healthcare | 1.75% | $175.41 | 2,057 | $720K |
| 14 | SUPNSupernus | Healthcare | 1.73% | $172.99 | 25K | $710K |
| 15 | ABBVAbbvie | Healthcare | 1.62% | $161.85 | 2,322 | $664K |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 21.15% |
| 2 | ARGNF | Argenx SE - | 5.03% |
| 3 | GH | Guardant Health | 3.45% |
| 4 | UTHR | United Therapeutics | 3.26% |
| 5 | INSM | Insmed | 3.25% |
| 6 | PCVX | Vaxcyte | 3.23% |
| 7 | RYTM | Rhythm Pharmaceuticals | 3.18% |
| 8 | IDXX | Idexx Laboratories | 2.60% |
| 9 | RVMD | Revolution Medicines | 2.52% |
| 10 | COR | Cencora | 2.23% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 19, 2025 | Dec 24, 2025 | $0.0751 |
| Dec 20, 2024 | Dec 26, 2024 | $0.13 |
| Dec 21, 2023 | Dec 27, 2023 | $0.46 |